Abstract
Objectives: Chronic obstructive pulmonary disease (COPD) as a liberal illness requires constant anti-inflammatory therapy. As praise of conventional treatments, patients often turn to alternate therapy. Current study aimed to evaluate the first study in Iran emphasizing on halotherapy influence on improving lung function testing results and relieving symptoms of Chronic Obstructive Pulmonary Disease patients, presented at respiratory referral hospital, Tehran in 2016.
Materials and Methods: In this double-blind clinical study, 84 components suffering from COPD detached to two experimental and control groups. Following two months treatment with salitair or placebo, one month clearance phase was carried. Eventually, groups were treated with salitair and placebo for next two months. Influence was determined assessed6-minute walk distant, arterial oxygen saturation drop of six minutes walking, CAT enquiry and spirometry FEV1, FVC and FEV1/FVC parameters.
Results: Current study revealed that halotherapy might exert a positive effect on 6-minute walk distant and arterial oxygen saturation drop of six minutes walking parameters, since has no effect on CAT enquiry and FEV1, FVC and FEV1/FVC parameters.
Conclusions: Advice for containing halotherapy as a healing treatment for COPD is doubtful. More studies are recommended to be done, including a larger study group to supply the best evidence.
Keywords: Chronic obstructive pulmonary disease; Spirometry; Vaporizers; Halotherapy; Spleotherapy; Salitair
References
1. Youssef D, Shams WE, Elshenawy Y, El-Abbassi A, Moorman JP.
Pulmonary infection with caseating mediastinal lymphadenitis caused by
Mycobacterium gordonae. Int J Mycobacteriol. 2014;3(3):220-3.
2. Bayram H. Effects of air pollution on respiratory health. Int J Mycobacteriol.
2015;4(1):59.
3. Mirsaeidi M, Sadikot RT. Gender susceptibility to mycobacterial infections
in patients with non-CF bronchiectasis. Int J Mycobacteriol. 2015;4(2):92-
6.
4. Mortaz E, Eslaminejad A, Varahram M, Heshmatnia J, Abedini A, Kiani
A, et al. Are There Any Epigenetic Similarities Between Treatment
Unresponsive Sarcoidosis, COPD and Severe Asthma? Iran J Allergy
Asthma Immunol. 2015;14(5):472-5.
5. Martinez Garcia L, McFarlane E, Barnes S, Sanabria AJ, Coello PA,
Alderson P. Updated recommendations: an assessment of NICE clinical
guidelines. Implement Sci. 2014;9:72.
6. Burkhardt R, Pankow W. [Chronic Obstructive Pulmonary Disease (COPD)
- Rational Diagnostics and Therapy]. Pneumologie. 2016;70(8):533-45.
7. Mathers CD, Loncar D. Projections of global mortality and burden of
disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
8. Abramson MJ, Crockett AJ, Frith PA, McDonald CF. COPDX: an update
of guidelines for the management of chronic obstructive pulmonary
disease with a review of recent evidence. Med J Aust. 2006;184(7):342-5.
9. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global
strategy for the diagnosis, management and prevention of COPD (GOLD)-
-why and what? Clin Respir J. 2012;6(4):208-14.
10. Sevostyanova EV, Nikolaev YA, Bogdankevich NV, Lusheva VG, Markova
EN, Dolgova NA. [Non-drug rehabilitation of patients with chronic
obstructive pulmonary disease concurrent with hypertension]. Ter Arkh.
2016;88(8):19-24.
11. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al.
Global strategy for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease: GOLD executive summary. Am J Respir
Crit Care Med. 2013;187(4):347-65.
12. Rashleigh R, Smith SM, Roberts NJ. A review of halotherapy for chronic
obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis.
2014;9:239-46.
13. Chervinskaya AV, Zilber NA. Halotherapy for treatment of respiratory
Kimia Taghavi, et al., Journal of Respiratory Medicine and Lung Disease
Remedy Publications LLC. 4 2017 | Volume 2 | Issue 5 | Article 1029
diseases. J Aerosol Med. 1995;8(3):221-32.
14. Abdrakhmanova LM, Farkhutdinov UR, Farkhutdinov RR. [Effectiveness
of halotherapy of chronic bronchitis patients]. Vopr Kurortol Fizioter
Lech Fiz Kult. 2000;(6):21-4.
15. Gorbenko PP, Adamova IV, Sinitsyna TM. [Bronchial hyperreactivity to
the inhalation of hypo- and hyperosmolar aerosols and its correction by
halotherapy]. Ter Arkh. 1996;68(8):24-8.
16. Farkhutdinov UR, Abdrakhmanova LM, Farkhutdinov RR. [Effects of
halotherapy on free radical oxidation in patients with chronic bronchitis].
Klin Med (Mosk). 2000;78(12):37-40.
17. Hedman J, Hugg T, Sandell J, Haahtela T. The effect of salt chamber
treatment on bronchial hyperresponsiveness in asthmatics. Allergy.
2006;61(5):605-10.
18. Endre L. [Theoretical basis and clinical benefits of dry salt inhalation
therapy]. Orv Hetil. 2015;156(41):1643-52.
19. Gelardi M, Iannuzzi L, Greco Miani A, Cazzaniga S, Naldi L, De Luca
C, et al. Double-blind placebo-controlled randomized clinical trial on
the efficacy of Aerosal in the treatment of sub-obstructive adenotonsillar
hypertrophy and related diseases. Int J Pediatr Otorhinolaryngol.
2013;77(11):1818-24.
20. Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M.
The global economic burden of asthma and chronic obstructive pulmonary
disease. Int J Tuberc Lung Dis. 2016;20(1):11-23.
21. Bar-Yoseph R, Kugelman N, Livnat G, Gur M, Hakim F, Nir V, et al.
Halotherapy as asthma treatment in children: A randomized, controlled,
prospective pilot study. Pediatr Pulmonol. 2017;52(5):580-587.
22. Rabbani B, Makki SSM, Najafizadeh K, Vishteh HRK, Shafaghi S, Karimi
S, et al. Efficacy of Halotherapy for Improvement of Pulmonary function
Tests and Quality of Life of Non-Cystic Fibrosis Bronchiectatic Patients.
Tanaffos. 2013;12(2):22-7.
23. Buttini F, Pasquali I, Brambilla G, Copelli D, Alberi MD, Balducci AG, et al.
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles
on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based
Dry Powder Inhaler. Pharm Res. 2016;33(3):701-15.
24. Zajac J, Bojar I, Helbin J, Kolarzyk E, Owoc A. Salt caves as simulation
of natural environment and significance of halotherapy. AAEM.
2014;21(1):124-7.